A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

An Optimized Protocol for the Generation of Vascular Organoids from Human Induced Pluripotent Stem Cells

278 views

⸱

DOI:

10.3791/73561

⸱

September 3rd, 2026

 ,  , 

In This Article

Summary

This protocol presents a method for generating vascular organoids using human induced pluripotent stem cells.

Abstract

Vascular organoids derived from human pluripotent stem cells (hPSCs) have emerged as powerful three-dimensional models for studying vascular development, disease mechanisms, and drug responses. Current vascular organoid protocols enable the generation of self-organizing endothelial–pericyte networks; however, batch-to-batch variability, inconsistent organoid formation, and inadequate pericyte coverage can compromise reproducibility and scalability. This study presents an optimized protocol for generating vascular organoids from human induced pluripotent stem cells (hiPSCs) with improved reproducibility and structural consistency. Key modifications include refined embryoid body formation conditions, optimized growth factor concentrations and timing during mesoderm induction and vascular specification, and improved three-dimensional culture conditions that promote robust pericyte recruitment and endothelial–pericyte interactions. The optimized organoids exhibit highly branched CD31-positive endothelial networks consistently ensheathed by PDGFR-β-positive pericytes, with significantly reduced batch-to-batch variability compared with the original protocol. Detailed, step-by-step procedures are provided for organoid generation, whole-mount immunofluorescence characterization, and quality control assessment. This optimized method enables the scalable production of high-quality vascular organoids suitable for studying vascular cell interactions, modeling disease, and screening compounds, thereby lowering the technical barrier for laboratories seeking to adopt this model system.

Introduction

Three-dimensional (3D) organoids have emerged as powerful tools for modeling human organ development and disease in vitro, offering superior structural biomimicry and pathophysiological relevance compared with conventional two-dimensional cell culture models1,2. In recent years, human pluripotent stem cell (hPSC)-derived organoids have been successfully established for multiple tissue types, including the intestine3, brain4,5, kidney6, liver7,8....

Access restricted. Please log in or start a trial to view this content.

Protocol

The use of hPSCs in this study was approved by the Biomedical Ethics Committee of Anhui University (BECAHU_2026-010).

1. Maintenance of human induced pluripotent stem cells

NOTE: Maintain human induced pluripotent stem cells (hiPSCs) under feeder-free conditions. Perform all procedures in a Class II biological safety cabinet using aseptic technique.

  1. Preparation of basement membrane matrix-coated culture plates
    1. Remove a vial of basement membrane matrix from −20 °C and thaw it at 4 °C overnight for approximately 12–16 h. Avoid repeated freeze–thaw....

Access restricted. Please log in or start a trial to view this content.

Results

The optimized protocol described here enables the generation of mature vascular organoids from hiPSCs within approximately 15 days using a stepwise differentiation strategy (Figure 1A). Briefly, hiPSC aggregates were generated in low-attachment plates supplemented with 0.25% PVA on an orbital shaker (Day −1). Mesoderm induction was initiated on Day 0 using CHIR99021 (12 µM) and BMP-4 (30 ng/mL) for 3 days, followed by vascular lineage specification with VEGF-A (100 ng/mL) and forskolin (2 µM.......

Access restricted. Please log in or start a trial to view this content.

Discussion

The optimized protocol described herein introduces several key improvements to the vascular organoid differentiation system originally established by Wimmer et al.18, with the aim of enhancing the homogeneity, reproducibility, and structural integrity of vascular organoid generation. Compared with the original protocol, the optimized method provides significant improvements in the following aspects. First, optimizing aggregate formation conditions substantially improves the homogeneity of embryoid.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare no competing financial interests.

Acknowledgements

This work was supported by the National Natural Science Foundation of China (NSFC) through the Young Scientists Fund (C) (No. 32200655) and the General Program (No. 32270847). The authors also thank the Anhui University Public Service Platform for its support.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
0.22 μm Bottle-Top FilterNalgeneFPE204030For sterile filtration of media and buffers
15 mL Conical TubeSparkJadeGD0001Sterile
2 mL Microcentrifuge TubeEppendorf22363204Sterile
2-Mercaptoethanol (1000×)Gibco21985023Use in fume hood
Alexa Fluor 488 AffiniPure F2 Fragment Donkey Anti-Rabbit IgG (H+L)LableadY1104Secondary antibody; dilute 1:300
Alexa Fluor 594 AffiniPure F(ab′)2 Fragment Donkey Anti-Goat IgG (H+L)LableadY1007Secondary antibody; dilute 1:300
Anti-CD31 antibodyCell Signaling3528sPrimary antibody; dilute 1:100 in blocking buffer
Anti PDGFR β antibodyZenbio347269Primary antibody; dilute 1:100 in blocking buffer
Automated Cell CounterLife TechnologiesCountess™ IIIncludes counting chamber slides
B27 Supplement (50×)Gibco17504044For N2B27 medium; thaw at 4ºC, aliquot and store at −20ºC, avoid freeze-thaw
Benchtop CentrifugeZonkiaSC-3610With swinging-bucket rotor
Biological Safety Cabinet (Class II)Thermo FisherNANA
BMP4ProteintechHZ-1045Reconstitute in sterile ddH2O to 100 ng/μL, aliquot and store at −20 °C
Bovine Serum Albumin (BSA)Biosharp9048-46-8For blocking buffer
CHIR99021MCEHY-10182Prepare 10 mM stock in DMSO, store at −20ºC for up to 1 year
CO2 IncubatorFisher ScientificLS-CO15037 ºC, 5% CO2, humidified
Confocal Imaging DishBiosharpBS-20-GJMFor imaging after staining
Confocal MicroscopeLEICANAEquipped with 10×, 20×, 63× objectives and ZEN software
DMEMVivacellC3113-0500For Matrigel dilution and collagen I solution
DMEM/F-12, GlutaMAX SupplementGibco10565018For Matrigel dilution and N2B27 medium
EDTA (0.5 M, pH 8.0)InvitrogenAM9260GDilute with PBS to 0.02% for passaging
Fetal Bovine Serum (FBS)Gibco10270-106For N2B27 complete differentiation medium (15% final)
FGF-2NovoproteinC046Prepare 1 mg/mL stock in sterile PBS, aliquot and store at −20ºC
ForskolinR&D Systems1099Prepare 10 mM stock in DMSO, store at −20ºC
HEPES (1M)Gibco15630080For collagen I solution
HoechstBeyotimeC1071S-4Prepare 1 mg/mL stock in deionized water, aliquot and store at −20ºC
Inverted MicroscopeLEICADMIL LEDRoutine cell observation
Matrigel (growth factor-reduced)STEEMABM05Store at −20ºC after aliquoting, avoid freeze-thaw; handle on ice
MEM Non-Essential Amino Acids Solution (NEAA, 100×)Gibco11140035For N2B27 medium
N2 Supplement (100×)Gibco17502048For N2B27 medium; store at −20ºC protected from light
Neurobasal MediumGibco21103049For N2B27 medium
Nuclease Free Water (DNase/Rnase Free)LableadDoo55WJFor RNA/cDNA preparation and qPCR
Orbital ShakerJoan LabNAFor washing steps
Paraformaldehyde (4% solution)ServicebioG1101Dilute with PBS to 4% for fixation; use in fume hood
Penicillin-Streptomycin (100×)Gibco15140122For N2B27 medium
PGM1 MediumCellapyA1517001hiPSC expansion medium; store at 4ºC protected from light, stable for 2 weeks
PGM1 Supplement (25×)CellapyA1517101For use with PGM1 Basal Medium
Polyvinyl Alcohol (PVA)Sigma-AldrichP8136Dissolve in PGM1 at 0.25% (w/v) to promote aggregation
PureCol (Bovine Type I Collagen, 3 mg/mL)Advanced BioMatrix5005For collagen I-Matrigel mixture; test batch for polymerization capacity
qPCR Thermal CyclerThermo FisherStepOnePlus™With melt curve capability; for real-time PCR detection
Reverse Transcription KitAccurate BiologyAG11706For cDNA synthesis from total RNA; contains RT master mix with reverse transcriptase, buffer, dNTPs, and random primers
RNA Extraction KitYeasen19221ES50For total RNA isolation from vascular organoids; includes gDNA elimination columns and RNase-free DNase I
Sodium Bicarbonate (7.5%)Gibco25080094For collagen I solution
Sodium DeoxycholateSigma-AldrichD6750Prepare 1% (w/v) solution in deionized water for blocking buffer
Sodium Hydroxide (1.0 N)Sigma-AldrichS2770For pH adjustment of collagen I solution
Sterile Disposable Pipettes (10 mL)Bkmamlab110205007Individually wrapped, sterile
Sterile Filter Pipette Tips (1000, 200, 20 μL)BiozymVT0270/VT0250/VT0220Sterile, with filter
Sterile Needle (30 G)NANAFor dissecting vascular networks
Sterile Spatula (Round End)Fisher Scientific21-401-5Stainless steel
SYBR Green Master MixAccurate BiologyAG117332× concentration for qPCR; contains hot-start DNA polymerase, buffer, dNTPs, and SYBR Green dye
Tissue Culture-Treated 12-Well PlateBD Falcon353043For gel embedding and vascular network culture
Tissue Culture-Treated 6-Well PlateEppendorf30720113Standard TC-treated
Triton X-100Sigma-AldrichT9084For blocking buffer
Trypan Blue (0.4%)Thermo Fisher15250061For cell counting
Tween 20Sigma-AldrichP7949For 0.05% PBS-T wash solution
Ultra-Low Attachment 6-Well PlateCorning3471For aggregate formation and differentiation
Ultra-Low Attachment Round-Bottom 96-Well PlateBeyotimeFULA962-6pcsFor suspension culture of vascular organoids
VEGF-AProteintechHZ-1038Prepare 1 mg/mL stock in sterile PBS, aliquot and store at −20ºC
Water BathBlue pardHWS-2437ºC
Y-27632MCEHY-10071Prepare 10 mM stock in sterile PBS or DMSO, store at −20ºC; working concentrations: 5 μM (thawing), 50 μM (aggregate formation)

References

  1. Lancaster MA, Knoblich JA. Organogenesis in a dish: modeling development and disease using organoid technologies. Science. 2014;345:1247125.
  2. Clevers H. Modeling development and disease with organoids. Cell. 2016;165:1586-1597.
  3. Spence JR, et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature. 2011;470:105-109.
  4. Lancaster MA, et al. Cerebral organoids model human brain development and microcephaly. Nature. 2013;501:373-379.
  5. Quadrato G, et al. Cell diversity and network dynamics in photosensitive human brain organoids. Nature. 2017;545:48-53.
  6. Takasato M, et al. Kidney organoids from huma....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Human Pluripotent Stem CellsOrganoid GenerationEmbryoid Body FormationMesoderm InductionVascular SpecificationPericyte RecruitmentEndothelial NetworksImmunofluorescence Characterization